Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin

Detalhes bibliográficos
Autor(a) principal: Costa, Jesus Eden Bezerra da
Data de Publicação: 2022
Outros Autores: Rodrigues Junior, Omero Martins, Almeida , Pablo Henrique Freitas de, Magalhães, Méllory Nétaly de Oliveira, Botero , Beatriz Fonseca, Silva, Ytalo Thiago Praciano da, Santos, Pâmela Bianca Barbosa dos, Lima, Maria Alves de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/31899
Resumo: Objective: The present study sought to analyze the existing scientific evidence to date on the adverse effects of the indiscriminate use of chloroquine, hydroxychloroquine and azithromycin in the COVID-19 pandemic. Material and Method: This is an integrative literature review with LILACS, PUBMED/MEDELINE and SCIELO databases, between 2019 and 2022. 75 articles were identified, of which 10 were used in the preparation of the work. the drugs chloroquine, hydroxychloroquine and azithromycin in the treatment of COVID-19 is low, due to the rapid spread and installation of the pandemic worldwide. It is necessary to carry out pragmatic clinical trials with a greater number of patients to analyze the effectiveness of fighting the coronavirus and the safety of using these drugs.
id UNIFEI_ac43c4f4a8e3f87ed6437e81a96b83dd
oai_identifier_str oai:ojs.pkp.sfu.ca:article/31899
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin Efectos adversos en el uso indiscriminado de medicamentos en la pandemia de COVID-19: una mirada a la cloroquina, la hidroxicloroquina y la azitromicina Efeitos adversos no uso indiscriminado de medicamentos na pandemia da COVID-19: um olhar sobre a cloroquina, hidroxicloroquina e azitromicina PandemiaCOVID-19Efeitos adversosCloroquinaHidroxicloroquinaAzitromicina. PandemiaCOVID-19Efectos adversosCloroquinaHidroxicloroquinaAzitromicina. PandemicCOVID-19Adverse effectsChloroquineHydroxychloroquineAzithromycin. Objective: The present study sought to analyze the existing scientific evidence to date on the adverse effects of the indiscriminate use of chloroquine, hydroxychloroquine and azithromycin in the COVID-19 pandemic. Material and Method: This is an integrative literature review with LILACS, PUBMED/MEDELINE and SCIELO databases, between 2019 and 2022. 75 articles were identified, of which 10 were used in the preparation of the work. the drugs chloroquine, hydroxychloroquine and azithromycin in the treatment of COVID-19 is low, due to the rapid spread and installation of the pandemic worldwide. It is necessary to carry out pragmatic clinical trials with a greater number of patients to analyze the effectiveness of fighting the coronavirus and the safety of using these drugs.Objetivo: El presente estudio buscó analizar la evidencia científica existente hasta la fecha sobre los efectos adversos del uso indiscriminado de cloroquina, hidroxicloroquina y azitromicina en la pandemia de COVID-19. Material y Método: Esta fue una revisión de literatura integradora con las bases de datos LILACS, PUBMED/MEDELINE y SCIELO, entre 2019 y 2022. Se identificaron 75 artículos, de los cuales 10 fueron utilizados en la elaboración del trabajo.Evidencia científica sobre la efectividad del los medicamentos cloroquina, hidroxicloroquina y azitromicina en el tratamiento del COVID-19 es escaso, debido a la rápida propagación e instalación de la pandemia en todo el mundo. Es necesario realizar ensayos clínicos pragmáticos con un mayor número de pacientes para analizar la eficacia de la lucha contra el coronavirus y la seguridad del uso de estos fármacos.Objetivo: o presente estudo buscou analisar as evidências científicas existentes até o presente momento sobre efeitos adversos no uso indiscriminado da cloroquina, hidroxicloroquina e azitromicina na pandemia da COVID-19. Material e Método: Tratou-se de uma revisão integrativa de literatura junto às bases de dados LILACS, PUBMED/MEDELINE e SCIELO, entre 2019 e 2022. Identificaram-se 75 artigos, sendo 10 utilizados na elaboração do trabalho.Resultados mostram que a literatura científica sobre a eficácia dos medicamentos cloroquina, hidroxicloroquina e azitromicina no tratamento da COVID-19 é escassa , devido à rápida disseminação e instalação da pandemia em todo o mundo. Há necessidade de ensaios clínicos pragmáticos envolvendo um número maior de pacientes para analisar a eficácia do combate ao coronavírus e a segurança do uso desses medicamentos.Research, Society and Development2022-07-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3189910.33448/rsd-v11i9.31899Research, Society and Development; Vol. 11 No. 9; e36611931899Research, Society and Development; Vol. 11 Núm. 9; e36611931899Research, Society and Development; v. 11 n. 9; e366119318992525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/31899/27220Copyright (c) 2022 Jesus Eden Bezerra da Costa; Omero Martins Rodrigues Junior; Pablo Henrique Freitas de Almeida ; Méllory Nétaly de Oliveira Magalhães; Beatriz Fonseca Botero ; Ytalo Thiago Praciano da Silva; Pâmela Bianca Barbosa dos Santos; Maria Alves de Limahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCosta, Jesus Eden Bezerra da Rodrigues Junior, Omero Martins Almeida , Pablo Henrique Freitas de Magalhães, Méllory Nétaly de Oliveira Botero , Beatriz Fonseca Silva, Ytalo Thiago Praciano da Santos, Pâmela Bianca Barbosa dos Lima, Maria Alves de 2022-07-21T12:36:16Zoai:ojs.pkp.sfu.ca:article/31899Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:48:04.765181Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
Efectos adversos en el uso indiscriminado de medicamentos en la pandemia de COVID-19: una mirada a la cloroquina, la hidroxicloroquina y la azitromicina
Efeitos adversos no uso indiscriminado de medicamentos na pandemia da COVID-19: um olhar sobre a cloroquina, hidroxicloroquina e azitromicina
title Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
spellingShingle Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
Costa, Jesus Eden Bezerra da
Pandemia
COVID-19
Efeitos adversos
Cloroquina
Hidroxicloroquina
Azitromicina.
Pandemia
COVID-19
Efectos adversos
Cloroquina
Hidroxicloroquina
Azitromicina.
Pandemic
COVID-19
Adverse effects
Chloroquine
Hydroxychloroquine
Azithromycin.
title_short Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
title_full Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
title_fullStr Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
title_full_unstemmed Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
title_sort Adverse effects in the indiscriminate use of medicines in the COVID-19 pandemic: a look at chloroquine, hydroxychloroquine and azithromycin
author Costa, Jesus Eden Bezerra da
author_facet Costa, Jesus Eden Bezerra da
Rodrigues Junior, Omero Martins
Almeida , Pablo Henrique Freitas de
Magalhães, Méllory Nétaly de Oliveira
Botero , Beatriz Fonseca
Silva, Ytalo Thiago Praciano da
Santos, Pâmela Bianca Barbosa dos
Lima, Maria Alves de
author_role author
author2 Rodrigues Junior, Omero Martins
Almeida , Pablo Henrique Freitas de
Magalhães, Méllory Nétaly de Oliveira
Botero , Beatriz Fonseca
Silva, Ytalo Thiago Praciano da
Santos, Pâmela Bianca Barbosa dos
Lima, Maria Alves de
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Costa, Jesus Eden Bezerra da
Rodrigues Junior, Omero Martins
Almeida , Pablo Henrique Freitas de
Magalhães, Méllory Nétaly de Oliveira
Botero , Beatriz Fonseca
Silva, Ytalo Thiago Praciano da
Santos, Pâmela Bianca Barbosa dos
Lima, Maria Alves de
dc.subject.por.fl_str_mv Pandemia
COVID-19
Efeitos adversos
Cloroquina
Hidroxicloroquina
Azitromicina.
Pandemia
COVID-19
Efectos adversos
Cloroquina
Hidroxicloroquina
Azitromicina.
Pandemic
COVID-19
Adverse effects
Chloroquine
Hydroxychloroquine
Azithromycin.
topic Pandemia
COVID-19
Efeitos adversos
Cloroquina
Hidroxicloroquina
Azitromicina.
Pandemia
COVID-19
Efectos adversos
Cloroquina
Hidroxicloroquina
Azitromicina.
Pandemic
COVID-19
Adverse effects
Chloroquine
Hydroxychloroquine
Azithromycin.
description Objective: The present study sought to analyze the existing scientific evidence to date on the adverse effects of the indiscriminate use of chloroquine, hydroxychloroquine and azithromycin in the COVID-19 pandemic. Material and Method: This is an integrative literature review with LILACS, PUBMED/MEDELINE and SCIELO databases, between 2019 and 2022. 75 articles were identified, of which 10 were used in the preparation of the work. the drugs chloroquine, hydroxychloroquine and azithromycin in the treatment of COVID-19 is low, due to the rapid spread and installation of the pandemic worldwide. It is necessary to carry out pragmatic clinical trials with a greater number of patients to analyze the effectiveness of fighting the coronavirus and the safety of using these drugs.
publishDate 2022
dc.date.none.fl_str_mv 2022-07-12
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/31899
10.33448/rsd-v11i9.31899
url https://rsdjournal.org/index.php/rsd/article/view/31899
identifier_str_mv 10.33448/rsd-v11i9.31899
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/31899/27220
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 9; e36611931899
Research, Society and Development; Vol. 11 Núm. 9; e36611931899
Research, Society and Development; v. 11 n. 9; e36611931899
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052717140541440

Registros relacionados